IRIS Accounts Production v23.4.0.336 07387589 director 7.4.22 6.4.23 6.4.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh073875892022-04-06073875892023-04-06073875892022-04-072023-04-06073875892021-04-06073875892021-04-072022-04-06073875892022-04-0607387589ns15:EnglandWales2022-04-072023-04-0607387589ns14:PoundSterling2022-04-072023-04-0607387589ns10:Director12022-04-072023-04-0607387589ns10:PrivateLimitedCompanyLtd2022-04-072023-04-0607387589ns10:SmallEntities2022-04-072023-04-0607387589ns10:AuditExempt-NoAccountantsReport2022-04-072023-04-0607387589ns10:SmallCompaniesRegimeForDirectorsReport2022-04-072023-04-0607387589ns10:SmallCompaniesRegimeForAccounts2022-04-072023-04-0607387589ns10:FullAccounts2022-04-072023-04-0607387589ns10:RegisteredOffice2022-04-072023-04-0607387589ns5:CurrentFinancialInstruments2023-04-0607387589ns5:CurrentFinancialInstruments2022-04-0607387589ns5:Non-currentFinancialInstruments2023-04-0607387589ns5:Non-currentFinancialInstruments2022-04-0607387589ns5:ShareCapital2023-04-0607387589ns5:ShareCapital2022-04-0607387589ns5:RetainedEarningsAccumulatedLosses2023-04-0607387589ns5:RetainedEarningsAccumulatedLosses2022-04-0607387589ns5:PlantMachinery2022-04-072023-04-0607387589ns5:MotorVehicles2022-04-072023-04-0607387589ns5:ComputerEquipment2022-04-072023-04-0607387589ns5:PlantMachinery2022-04-0607387589ns5:MotorVehicles2022-04-0607387589ns5:ComputerEquipment2022-04-0607387589ns5:PlantMachinery2023-04-0607387589ns5:MotorVehicles2023-04-0607387589ns5:ComputerEquipment2023-04-0607387589ns5:PlantMachinery2022-04-0607387589ns5:MotorVehicles2022-04-0607387589ns5:ComputerEquipment2022-04-0607387589ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-0607387589ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-04-0607387589ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-04-0607387589ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2022-04-06073875891ns10:Director12022-04-06073875891ns10:Director12021-04-06073875891ns10:Director12022-04-072023-04-06073875891ns10:Director12021-04-072022-04-06073875891ns10:Director12023-04-06073875891ns10:Director12022-04-06
REGISTERED NUMBER: 07387589 (England and Wales)







UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 6 APRIL 2023

FOR

OCTAGON SURGERY LIMITED

OCTAGON SURGERY LIMITED (REGISTERED NUMBER: 07387589)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 6 APRIL 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


OCTAGON SURGERY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 6 APRIL 2023







DIRECTOR: Mr A G K Li





REGISTERED OFFICE: Rex Buildings
Alderley Road
Wilmslow
Cheshire
SK9 1HY





REGISTERED NUMBER: 07387589 (England and Wales)

OCTAGON SURGERY LIMITED (REGISTERED NUMBER: 07387589)

BALANCE SHEET
6 APRIL 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 95,040 34,099

CURRENT ASSETS
Debtors 5 737,990 669,242
Cash at bank 1,512 6,280
739,502 675,522
CREDITORS
Amounts falling due within one year 6 253,651 207,683
NET CURRENT ASSETS 485,851 467,839
TOTAL ASSETS LESS CURRENT
LIABILITIES

580,891

501,938

CREDITORS
Amounts falling due after more than
one year

7

(106,509

)

(40,911

)

PROVISIONS FOR LIABILITIES (18,057 ) (6,478 )
NET ASSETS 456,325 454,549

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 456,225 454,449
456,325 454,549

OCTAGON SURGERY LIMITED (REGISTERED NUMBER: 07387589)

BALANCE SHEET - continued
6 APRIL 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 6 April 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 6 April 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 3 April 2024 and were signed by:





Mr A G K Li - Director


OCTAGON SURGERY LIMITED (REGISTERED NUMBER: 07387589)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 6 APRIL 2023

1. STATUTORY INFORMATION

Octagon Surgery Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

RELATED PARTY EXEMPTION
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

TURNOVER
The turnover shown in the profit and loss account represents amounts earned during the year and is recognised when the company obtains the right to consideration.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Plant and machinery - 15% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on cost

All fixed assets are initially recorded at cost.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

OCTAGON SURGERY LIMITED (REGISTERED NUMBER: 07387589)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 6 APRIL 2023

4. TANGIBLE FIXED ASSETS
Plant and Motor Computer
machinery vehicles equipment Totals
£    £    £    £   
COST
At 7 April 2022 1,000 158,860 4,756 164,616
Additions - 125,574 - 125,574
Disposals - (158,860 ) - (158,860 )
At 6 April 2023 1,000 125,574 4,756 131,330
DEPRECIATION
At 7 April 2022 748 125,874 3,895 130,517
Charge for year 38 31,394 215 31,647
Eliminated on disposal - (125,874 ) - (125,874 )
At 6 April 2023 786 31,394 4,110 36,290
NET BOOK VALUE
At 6 April 2023 214 94,180 646 95,040
At 6 April 2022 252 32,986 861 34,099

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 63,948 200
Other debtors 164,324 164,324
Debtors 5,000 -
Directors' current accounts 504,718 504,718
737,990 669,242

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Finance leases 26,166 -
Tax 216,363 194,719
Accrued expenses 11,122 12,964
253,651 207,683

OCTAGON SURGERY LIMITED (REGISTERED NUMBER: 07387589)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 6 APRIL 2023

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bounce Back Loan 30,192 40,911
Finance leases 76,317 -
106,509 40,911

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 6 April 2023 and 6 April 2022:

2023 2022
£    £   
Mr A G K Li
Balance outstanding at start of year 504,717 504,717
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 504,717 504,717

The advanced loan to the director incurred an interest of 2%.